P1247: GB5121 IS A NOVEL, IRREVERSIBLE, COVALENT BTK INHIBITOR WITH HIGH SELECTIVITY AND CNS-PENETRANCE FOR TREATMENT OF CNS MALIGNANCIES

• I. Yusuf,
• D. Guimond,
• Z. Naiman,
• T. Schiff,
• B. Clemons,
• B. Paulson,
• K. Hou,
• K. Taylor Meadows,
• M. Rose,
• L. Carter

Affiliations

I. Yusuf

1 Gossamer Bio, Inc., San Diego, CA, United States of America

D. Guimond

1 Gossamer Bio, Inc., San Diego, CA, United States of America

Z. Naiman

1 Gossamer Bio, Inc., San Diego, CA, United States of America

T. Schiff

1 Gossamer Bio, Inc., San Diego, CA, United States of America

B. Clemons

1 Gossamer Bio, Inc., San Diego, CA, United States of America

B. Paulson

1 Gossamer Bio, Inc., San Diego, CA, United States of America

K. Hou

1 Gossamer Bio, Inc., San Diego, CA, United States of America

K. Taylor Meadows

1 Gossamer Bio, Inc., San Diego, CA, United States of America

M. Rose

1 Gossamer Bio, Inc., San Diego, CA, United States of America

L. Carter

1 Gossamer Bio, Inc., San Diego, CA, United States of America